7-82136680-CAA-CA

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP6_Very_StrongBS2

The NM_000722.4(CACNA2D1):​c.355-5delT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00448 in 1,292,524 control chromosomes in the GnomAD database, including 1 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.00019 ( 0 hom., cov: 30)
Exomes 𝑓: 0.0050 ( 1 hom. )

Consequence

CACNA2D1
NM_000722.4 splice_region, intron

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.0210
Variant links:
Genes affected
CACNA2D1 (HGNC:1399): (calcium voltage-gated channel auxiliary subunit alpha2delta 1) The preproprotein encoded by this gene is cleaved into multiple chains that comprise the alpha-2 and delta subunits of the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. Mutations in this gene can cause cardiac deficiencies, including Brugada syndrome and short QT syndrome. Alternate splicing results in multiple transcript variants, some of which may lack the delta subunit portion. [provided by RefSeq, Nov 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP6
Variant 7-82136680-CA-C is Benign according to our data. Variant chr7-82136680-CA-C is described in ClinVar as [Benign]. Clinvar id is 221019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-82136680-CA-C is described in Lovd as [Benign]. Variant chr7-82136680-CA-C is described in Lovd as [Benign].
BS2
High AC in GnomAd4 at 27 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA2D1NM_000722.4 linkc.355-5delT splice_region_variant, intron_variant Intron 4 of 38 ENST00000356860.8 NP_000713.2 P54289-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA2D1ENST00000356860.8 linkc.355-5delT splice_region_variant, intron_variant Intron 4 of 38 1 NM_000722.4 ENSP00000349320.3 P54289-2

Frequencies

GnomAD3 genomes
AF:
0.000187
AC:
26
AN:
139182
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.000131
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000727
Gnomad ASJ
AF:
0.000305
Gnomad EAS
AF:
0.000413
Gnomad SAS
AF:
0.000454
Gnomad FIN
AF:
0.000486
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000173
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0145
AC:
1693
AN:
116500
Hom.:
0
AF XY:
0.0153
AC XY:
953
AN XY:
62424
show subpopulations
Gnomad AFR exome
AF:
0.00746
Gnomad AMR exome
AF:
0.0134
Gnomad ASJ exome
AF:
0.0101
Gnomad EAS exome
AF:
0.0124
Gnomad SAS exome
AF:
0.0165
Gnomad FIN exome
AF:
0.0136
Gnomad NFE exome
AF:
0.0164
Gnomad OTH exome
AF:
0.0160
GnomAD4 exome
AF:
0.00499
AC:
5760
AN:
1153250
Hom.:
1
Cov.:
25
AF XY:
0.00498
AC XY:
2843
AN XY:
571038
show subpopulations
Gnomad4 AFR exome
AF:
0.00587
Gnomad4 AMR exome
AF:
0.00814
Gnomad4 ASJ exome
AF:
0.00298
Gnomad4 EAS exome
AF:
0.00182
Gnomad4 SAS exome
AF:
0.00650
Gnomad4 FIN exome
AF:
0.00546
Gnomad4 NFE exome
AF:
0.00494
Gnomad4 OTH exome
AF:
0.00418
GnomAD4 genome
AF:
0.000194
AC:
27
AN:
139274
Hom.:
0
Cov.:
30
AF XY:
0.000208
AC XY:
14
AN XY:
67300
show subpopulations
Gnomad4 AFR
AF:
0.000131
Gnomad4 AMR
AF:
0.000145
Gnomad4 ASJ
AF:
0.000305
Gnomad4 EAS
AF:
0.000414
Gnomad4 SAS
AF:
0.000456
Gnomad4 FIN
AF:
0.000486
Gnomad4 NFE
AF:
0.000173
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0159
Hom.:
11

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Brugada syndrome Benign:1
Jan 15, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Cardiovascular phenotype Benign:1
Oct 21, 2019
Ambry Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs142849270; hg19: chr7-81765996; API